ASCENDIS PHARMA A/S - ADR (ASND) Stock Analyst Ratings
NASDAQ:ASND - Nasdaq - US04351P1012 - ADR - Currency: USD
ChartMill assigns a Buy % Consensus number of 87% to ASND. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 207.06. This target is 35.84% above the current price.
ASND was analyzed by 22 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about ASND.
In the previous month the buy percentage consensus was at a similar level.
ASND was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-18 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-02-13 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-02-13 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-02-11 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-01-29 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-01-07 | UBS | Initiate | Buy |
| 2024-11-15 | TD Cowen | Maintains | Buy -> Buy |
| 2024-11-15 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-11-15 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-11-15 | Stifel | Maintains | Buy -> Buy |
| 2024-11-15 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-11-04 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-10-23 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-10-21 | TD Cowen | Maintains | Buy -> Buy |
| 2024-09-23 | B of A Securities | Maintains | Buy -> Buy |
| 2024-09-17 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-09-17 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-09-17 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-09-17 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-09-17 | Citigroup | Maintains | Buy -> Buy |
| 2024-09-16 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-05 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2024-09-04 | TD Cowen | Maintains | Buy -> Buy |
| 2024-09-04 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-09-04 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-09-04 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-09-04 | B of A Securities | Maintains | Buy -> Buy |
| 2024-09-04 | Citigroup | Maintains | Buy -> Buy |
| 2024-08-21 | JP Morgan | Maintains | Overweight -> Overweight |